The SmallCapInvestor.com Top 25 Composite

The SmallCapInvestor.com Top 25 Composite is a computer-generated ranking of the leading stocks in the small cap universe. Rankings are based on a stocks fundamentals, projected growth rates, institutional sponsorship, and technical trend lines. This composite is comprised of stocks that are showing an increasing relative strength to the Russell 2000. As a result, this index should outperform the Russell over long periods of time. A company's inclusion in the ranking should not be viewed as a recommendation.

Decliners led advancers 3:2

Stocks showing leadership:

- CVTX
- MFLX
- IMA
- WES
- EQIQ

The SmallCapInvestor.com Top 25 lost about 2% over the past week. Despite the losses last week, the composite is still beating the Russell 2000 by 3.7% since our inception. Decliners led advancers 3 to 2 in the SmallCapInvestor.com Top 25 last week suggesting a bearish trend in the markets. We did manage to capture a few nice gainers despite the volatility in the stock market. Leading the list last week was CV Therapeutics (Nasdaq: CVTX), Multi-Fineline Electronix (Nasdaq: MFLX), and Inverness Medical Innovations Inc (NYSE: IMA), up 36.9%, 6.5% and 3.5% for the week.

Last week Astellas announced a $16 per share bid for CV Therapeutics sending shares soaring 40% to over $16. Shares closed the week at $15.65 up 37%. This gain follows the previous weeks 7% gain, which equates to a 44.5% total gain since our coverage began two weeks ago. The stock is now out of the SmallCapInvestor.com Top 25 since the company is expected to be acquired.

Here are the top 25 stocks for the week of February 2, 2009...

For access to the full article, you must be a registered member - it's FREE.

Already a member? Please log in below